Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI)
AFCKDI RECOMMENDATIONS FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE 1. Targets Patients with diabetes, hypertension Those with family history of chronic kidney disease (CKD) Individuals receiving potentially nephrotoxic drugs, herbs or substances or taking indigenous medicine Patients with past his...
Gespeichert in:
Veröffentlicht in: | Nephrology (Carlton, Vic.) Vic.), 2011-09, Vol.16 (7), p.633-641 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 641 |
---|---|
container_issue | 7 |
container_start_page | 633 |
container_title | Nephrology (Carlton, Vic.) |
container_volume | 16 |
creator | LI, PHILIP KAM-TAO CHOW, KAI MING MATSUO, SEIICHI YANG, CHIH WEI JHA, VIVEKANAND BECKER, GAVIN CHEN, NAN SHARMA, SANJIB KUMAR CHITTINANDANA, ANUTRA CHOWDHURY, SHAFIQUL HARRIS, DAVID C.H. HOOI, LAI SEONG IMAI, ENYU KIM, SUHNGGWON KIM, SUNG GYUN LANGHAM, ROBYN PADILLA, BENITA S. TEO, BOON WEE TOGTOKH, ARIUNAA WALKER, ROWAN G. WANG, HAI YAN TSUKAMOTO, YUSUKE |
description | AFCKDI RECOMMENDATIONS FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE
1. Targets
Patients with diabetes, hypertension
Those with family history of chronic kidney disease (CKD)
Individuals receiving potentially nephrotoxic drugs, herbs or substances or taking indigenous medicine
Patients with past history of acute kidney injury
Individuals older than 65 years
2. Tools
Spot urine sample for protein with standard urine Dipstick test (need a repeat confirmatory test if positive)
Dipstick for red blood cells (need confirmation by urine microscopy)
An estimate of glomerular filtration rate based on serum creatinine concentration
3. Frequency of screening
Screening frequency for targeted individuals should be yearly if no abnormality is detected on initial evaluation.
4. Who should perform the screening
Doctors, nurses, paramedical staff and other trained healthcare professionals
5. Intervention after screening
Patients detected to have CKD should be referred to primary care physicians with experience in management of kidney disease for follow up. A management protocol should be provided to the primary care physicians. Further referral to nephrologists for management will be based on the protocol together with clinical judgment of the primary care physicians with their assessment of the severity of CKD and the likelihood of progression.
6. Screening for cardiovascular disease risk
It is recommended that cardiovascular disease risk factors should be screened in all patients with CKD.
These guidelines relate to screening for chronic kidney disease, specifically in an Asian setting. They draw on considerable experience across Asia from a specially convened workshop. |
doi_str_mv | 10.1111/j.1440-1797.2011.01503.x |
format | Article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_21771177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NEP1503</sourcerecordid><originalsourceid>FETCH-LOGICAL-i3023-d8405726c78d279d7266a65815b263e5ca18b1d3eee07aca1451a3fbe542739f3</originalsourceid><addsrcrecordid>eNp1UctOwzAQtBCI9y8gH-GQYMdxnCJxqPqiFJUigThaTrIRLk1S2Sm0f8en4TSlNyxZHmtndtYehDAlPnXrdu7TMCQeFR3hB4RSn1BOmL8-QKf7wqHDLCAeZzw-QWfWzgmhIojoMToJqBDU7VP007ValTj9MFWpU_ypsxI2ONMWlAWcgK3x0qi01ilgA2lVFFBmqtZVae_wrLK6gWqBba1qcLXa4rwyGJRZuDZQQ9oQcJX_Z5GbqsDtEMPKrIqtvLfjTlpuf8cdl87OmX-BxdfdYW_SH99coKNcLSxc7s5z9DYcvPYevKfn0bjXffI0IwHzsjgk3L0-FXEWiE7mYKQiHlOeBBEDnioaJzRjAECEcreQU8XyBHgYCNbJ2Tm6avsuV0kBmVwaXSizkX9f6Qj3LeFbL2Czr1Mim8jkXDbJyCYZ2UQmt5HJtZwOZg1yeq_Va1vDeq9X5lNGggku36cjOe3PXh4nTMiQ_QKHD5xT</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>LI, PHILIP KAM-TAO ; CHOW, KAI MING ; MATSUO, SEIICHI ; YANG, CHIH WEI ; JHA, VIVEKANAND ; BECKER, GAVIN ; CHEN, NAN ; SHARMA, SANJIB KUMAR ; CHITTINANDANA, ANUTRA ; CHOWDHURY, SHAFIQUL ; HARRIS, DAVID C.H. ; HOOI, LAI SEONG ; IMAI, ENYU ; KIM, SUHNGGWON ; KIM, SUNG GYUN ; LANGHAM, ROBYN ; PADILLA, BENITA S. ; TEO, BOON WEE ; TOGTOKH, ARIUNAA ; WALKER, ROWAN G. ; WANG, HAI YAN ; TSUKAMOTO, YUSUKE</creator><creatorcontrib>LI, PHILIP KAM-TAO ; CHOW, KAI MING ; MATSUO, SEIICHI ; YANG, CHIH WEI ; JHA, VIVEKANAND ; BECKER, GAVIN ; CHEN, NAN ; SHARMA, SANJIB KUMAR ; CHITTINANDANA, ANUTRA ; CHOWDHURY, SHAFIQUL ; HARRIS, DAVID C.H. ; HOOI, LAI SEONG ; IMAI, ENYU ; KIM, SUHNGGWON ; KIM, SUNG GYUN ; LANGHAM, ROBYN ; PADILLA, BENITA S. ; TEO, BOON WEE ; TOGTOKH, ARIUNAA ; WALKER, ROWAN G. ; WANG, HAI YAN ; TSUKAMOTO, YUSUKE ; Asian Forum for Chronic Kidney Disease Initiatives</creatorcontrib><description>AFCKDI RECOMMENDATIONS FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE
1. Targets
Patients with diabetes, hypertension
Those with family history of chronic kidney disease (CKD)
Individuals receiving potentially nephrotoxic drugs, herbs or substances or taking indigenous medicine
Patients with past history of acute kidney injury
Individuals older than 65 years
2. Tools
Spot urine sample for protein with standard urine Dipstick test (need a repeat confirmatory test if positive)
Dipstick for red blood cells (need confirmation by urine microscopy)
An estimate of glomerular filtration rate based on serum creatinine concentration
3. Frequency of screening
Screening frequency for targeted individuals should be yearly if no abnormality is detected on initial evaluation.
4. Who should perform the screening
Doctors, nurses, paramedical staff and other trained healthcare professionals
5. Intervention after screening
Patients detected to have CKD should be referred to primary care physicians with experience in management of kidney disease for follow up. A management protocol should be provided to the primary care physicians. Further referral to nephrologists for management will be based on the protocol together with clinical judgment of the primary care physicians with their assessment of the severity of CKD and the likelihood of progression.
6. Screening for cardiovascular disease risk
It is recommended that cardiovascular disease risk factors should be screened in all patients with CKD.
These guidelines relate to screening for chronic kidney disease, specifically in an Asian setting. They draw on considerable experience across Asia from a specially convened workshop.</description><identifier>ISSN: 1320-5358</identifier><identifier>EISSN: 1440-1797</identifier><identifier>DOI: 10.1111/j.1440-1797.2011.01503.x</identifier><identifier>PMID: 21771177</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Asia - epidemiology ; Asian Continental Ancestry Group ; Benchmarking ; Chronic Disease ; chronic kidney disease ; Early Diagnosis ; guidelines ; high risk populations ; Humans ; Kidney Diseases - diagnosis ; Kidney Diseases - ethnology ; Kidney Diseases - etiology ; Mass Screening - methods ; Predictive Value of Tests ; Prognosis ; Risk Assessment ; Risk Factors</subject><ispartof>Nephrology (Carlton, Vic.), 2011-09, Vol.16 (7), p.633-641</ispartof><rights>2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1797.2011.01503.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1797.2011.01503.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21771177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LI, PHILIP KAM-TAO</creatorcontrib><creatorcontrib>CHOW, KAI MING</creatorcontrib><creatorcontrib>MATSUO, SEIICHI</creatorcontrib><creatorcontrib>YANG, CHIH WEI</creatorcontrib><creatorcontrib>JHA, VIVEKANAND</creatorcontrib><creatorcontrib>BECKER, GAVIN</creatorcontrib><creatorcontrib>CHEN, NAN</creatorcontrib><creatorcontrib>SHARMA, SANJIB KUMAR</creatorcontrib><creatorcontrib>CHITTINANDANA, ANUTRA</creatorcontrib><creatorcontrib>CHOWDHURY, SHAFIQUL</creatorcontrib><creatorcontrib>HARRIS, DAVID C.H.</creatorcontrib><creatorcontrib>HOOI, LAI SEONG</creatorcontrib><creatorcontrib>IMAI, ENYU</creatorcontrib><creatorcontrib>KIM, SUHNGGWON</creatorcontrib><creatorcontrib>KIM, SUNG GYUN</creatorcontrib><creatorcontrib>LANGHAM, ROBYN</creatorcontrib><creatorcontrib>PADILLA, BENITA S.</creatorcontrib><creatorcontrib>TEO, BOON WEE</creatorcontrib><creatorcontrib>TOGTOKH, ARIUNAA</creatorcontrib><creatorcontrib>WALKER, ROWAN G.</creatorcontrib><creatorcontrib>WANG, HAI YAN</creatorcontrib><creatorcontrib>TSUKAMOTO, YUSUKE</creatorcontrib><creatorcontrib>Asian Forum for Chronic Kidney Disease Initiatives</creatorcontrib><title>Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI)</title><title>Nephrology (Carlton, Vic.)</title><addtitle>Nephrology (Carlton)</addtitle><description>AFCKDI RECOMMENDATIONS FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE
1. Targets
Patients with diabetes, hypertension
Those with family history of chronic kidney disease (CKD)
Individuals receiving potentially nephrotoxic drugs, herbs or substances or taking indigenous medicine
Patients with past history of acute kidney injury
Individuals older than 65 years
2. Tools
Spot urine sample for protein with standard urine Dipstick test (need a repeat confirmatory test if positive)
Dipstick for red blood cells (need confirmation by urine microscopy)
An estimate of glomerular filtration rate based on serum creatinine concentration
3. Frequency of screening
Screening frequency for targeted individuals should be yearly if no abnormality is detected on initial evaluation.
4. Who should perform the screening
Doctors, nurses, paramedical staff and other trained healthcare professionals
5. Intervention after screening
Patients detected to have CKD should be referred to primary care physicians with experience in management of kidney disease for follow up. A management protocol should be provided to the primary care physicians. Further referral to nephrologists for management will be based on the protocol together with clinical judgment of the primary care physicians with their assessment of the severity of CKD and the likelihood of progression.
6. Screening for cardiovascular disease risk
It is recommended that cardiovascular disease risk factors should be screened in all patients with CKD.
These guidelines relate to screening for chronic kidney disease, specifically in an Asian setting. They draw on considerable experience across Asia from a specially convened workshop.</description><subject>Asia - epidemiology</subject><subject>Asian Continental Ancestry Group</subject><subject>Benchmarking</subject><subject>Chronic Disease</subject><subject>chronic kidney disease</subject><subject>Early Diagnosis</subject><subject>guidelines</subject><subject>high risk populations</subject><subject>Humans</subject><subject>Kidney Diseases - diagnosis</subject><subject>Kidney Diseases - ethnology</subject><subject>Kidney Diseases - etiology</subject><subject>Mass Screening - methods</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><issn>1320-5358</issn><issn>1440-1797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UctOwzAQtBCI9y8gH-GQYMdxnCJxqPqiFJUigThaTrIRLk1S2Sm0f8en4TSlNyxZHmtndtYehDAlPnXrdu7TMCQeFR3hB4RSn1BOmL8-QKf7wqHDLCAeZzw-QWfWzgmhIojoMToJqBDU7VP007ValTj9MFWpU_ypsxI2ONMWlAWcgK3x0qi01ilgA2lVFFBmqtZVae_wrLK6gWqBba1qcLXa4rwyGJRZuDZQQ9oQcJX_Z5GbqsDtEMPKrIqtvLfjTlpuf8cdl87OmX-BxdfdYW_SH99coKNcLSxc7s5z9DYcvPYevKfn0bjXffI0IwHzsjgk3L0-FXEWiE7mYKQiHlOeBBEDnioaJzRjAECEcreQU8XyBHgYCNbJ2Tm6avsuV0kBmVwaXSizkX9f6Qj3LeFbL2Czr1Mim8jkXDbJyCYZ2UQmt5HJtZwOZg1yeq_Va1vDeq9X5lNGggku36cjOe3PXh4nTMiQ_QKHD5xT</recordid><startdate>201109</startdate><enddate>201109</enddate><creator>LI, PHILIP KAM-TAO</creator><creator>CHOW, KAI MING</creator><creator>MATSUO, SEIICHI</creator><creator>YANG, CHIH WEI</creator><creator>JHA, VIVEKANAND</creator><creator>BECKER, GAVIN</creator><creator>CHEN, NAN</creator><creator>SHARMA, SANJIB KUMAR</creator><creator>CHITTINANDANA, ANUTRA</creator><creator>CHOWDHURY, SHAFIQUL</creator><creator>HARRIS, DAVID C.H.</creator><creator>HOOI, LAI SEONG</creator><creator>IMAI, ENYU</creator><creator>KIM, SUHNGGWON</creator><creator>KIM, SUNG GYUN</creator><creator>LANGHAM, ROBYN</creator><creator>PADILLA, BENITA S.</creator><creator>TEO, BOON WEE</creator><creator>TOGTOKH, ARIUNAA</creator><creator>WALKER, ROWAN G.</creator><creator>WANG, HAI YAN</creator><creator>TSUKAMOTO, YUSUKE</creator><general>Blackwell Publishing Asia</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201109</creationdate><title>Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI)</title><author>LI, PHILIP KAM-TAO ; CHOW, KAI MING ; MATSUO, SEIICHI ; YANG, CHIH WEI ; JHA, VIVEKANAND ; BECKER, GAVIN ; CHEN, NAN ; SHARMA, SANJIB KUMAR ; CHITTINANDANA, ANUTRA ; CHOWDHURY, SHAFIQUL ; HARRIS, DAVID C.H. ; HOOI, LAI SEONG ; IMAI, ENYU ; KIM, SUHNGGWON ; KIM, SUNG GYUN ; LANGHAM, ROBYN ; PADILLA, BENITA S. ; TEO, BOON WEE ; TOGTOKH, ARIUNAA ; WALKER, ROWAN G. ; WANG, HAI YAN ; TSUKAMOTO, YUSUKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i3023-d8405726c78d279d7266a65815b263e5ca18b1d3eee07aca1451a3fbe542739f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Asia - epidemiology</topic><topic>Asian Continental Ancestry Group</topic><topic>Benchmarking</topic><topic>Chronic Disease</topic><topic>chronic kidney disease</topic><topic>Early Diagnosis</topic><topic>guidelines</topic><topic>high risk populations</topic><topic>Humans</topic><topic>Kidney Diseases - diagnosis</topic><topic>Kidney Diseases - ethnology</topic><topic>Kidney Diseases - etiology</topic><topic>Mass Screening - methods</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LI, PHILIP KAM-TAO</creatorcontrib><creatorcontrib>CHOW, KAI MING</creatorcontrib><creatorcontrib>MATSUO, SEIICHI</creatorcontrib><creatorcontrib>YANG, CHIH WEI</creatorcontrib><creatorcontrib>JHA, VIVEKANAND</creatorcontrib><creatorcontrib>BECKER, GAVIN</creatorcontrib><creatorcontrib>CHEN, NAN</creatorcontrib><creatorcontrib>SHARMA, SANJIB KUMAR</creatorcontrib><creatorcontrib>CHITTINANDANA, ANUTRA</creatorcontrib><creatorcontrib>CHOWDHURY, SHAFIQUL</creatorcontrib><creatorcontrib>HARRIS, DAVID C.H.</creatorcontrib><creatorcontrib>HOOI, LAI SEONG</creatorcontrib><creatorcontrib>IMAI, ENYU</creatorcontrib><creatorcontrib>KIM, SUHNGGWON</creatorcontrib><creatorcontrib>KIM, SUNG GYUN</creatorcontrib><creatorcontrib>LANGHAM, ROBYN</creatorcontrib><creatorcontrib>PADILLA, BENITA S.</creatorcontrib><creatorcontrib>TEO, BOON WEE</creatorcontrib><creatorcontrib>TOGTOKH, ARIUNAA</creatorcontrib><creatorcontrib>WALKER, ROWAN G.</creatorcontrib><creatorcontrib>WANG, HAI YAN</creatorcontrib><creatorcontrib>TSUKAMOTO, YUSUKE</creatorcontrib><creatorcontrib>Asian Forum for Chronic Kidney Disease Initiatives</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Nephrology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LI, PHILIP KAM-TAO</au><au>CHOW, KAI MING</au><au>MATSUO, SEIICHI</au><au>YANG, CHIH WEI</au><au>JHA, VIVEKANAND</au><au>BECKER, GAVIN</au><au>CHEN, NAN</au><au>SHARMA, SANJIB KUMAR</au><au>CHITTINANDANA, ANUTRA</au><au>CHOWDHURY, SHAFIQUL</au><au>HARRIS, DAVID C.H.</au><au>HOOI, LAI SEONG</au><au>IMAI, ENYU</au><au>KIM, SUHNGGWON</au><au>KIM, SUNG GYUN</au><au>LANGHAM, ROBYN</au><au>PADILLA, BENITA S.</au><au>TEO, BOON WEE</au><au>TOGTOKH, ARIUNAA</au><au>WALKER, ROWAN G.</au><au>WANG, HAI YAN</au><au>TSUKAMOTO, YUSUKE</au><aucorp>Asian Forum for Chronic Kidney Disease Initiatives</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI)</atitle><jtitle>Nephrology (Carlton, Vic.)</jtitle><addtitle>Nephrology (Carlton)</addtitle><date>2011-09</date><risdate>2011</risdate><volume>16</volume><issue>7</issue><spage>633</spage><epage>641</epage><pages>633-641</pages><issn>1320-5358</issn><eissn>1440-1797</eissn><abstract>AFCKDI RECOMMENDATIONS FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE
1. Targets
Patients with diabetes, hypertension
Those with family history of chronic kidney disease (CKD)
Individuals receiving potentially nephrotoxic drugs, herbs or substances or taking indigenous medicine
Patients with past history of acute kidney injury
Individuals older than 65 years
2. Tools
Spot urine sample for protein with standard urine Dipstick test (need a repeat confirmatory test if positive)
Dipstick for red blood cells (need confirmation by urine microscopy)
An estimate of glomerular filtration rate based on serum creatinine concentration
3. Frequency of screening
Screening frequency for targeted individuals should be yearly if no abnormality is detected on initial evaluation.
4. Who should perform the screening
Doctors, nurses, paramedical staff and other trained healthcare professionals
5. Intervention after screening
Patients detected to have CKD should be referred to primary care physicians with experience in management of kidney disease for follow up. A management protocol should be provided to the primary care physicians. Further referral to nephrologists for management will be based on the protocol together with clinical judgment of the primary care physicians with their assessment of the severity of CKD and the likelihood of progression.
6. Screening for cardiovascular disease risk
It is recommended that cardiovascular disease risk factors should be screened in all patients with CKD.
These guidelines relate to screening for chronic kidney disease, specifically in an Asian setting. They draw on considerable experience across Asia from a specially convened workshop.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>21771177</pmid><doi>10.1111/j.1440-1797.2011.01503.x</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1320-5358 |
ispartof | Nephrology (Carlton, Vic.), 2011-09, Vol.16 (7), p.633-641 |
issn | 1320-5358 1440-1797 |
language | eng |
recordid | cdi_pubmed_primary_21771177 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Asia - epidemiology Asian Continental Ancestry Group Benchmarking Chronic Disease chronic kidney disease Early Diagnosis guidelines high risk populations Humans Kidney Diseases - diagnosis Kidney Diseases - ethnology Kidney Diseases - etiology Mass Screening - methods Predictive Value of Tests Prognosis Risk Assessment Risk Factors |
title | Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T21%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Asian%20chronic%20kidney%20disease%20best%20practice%20recommendations:%20Positional%20statements%20for%20early%20detection%20of%20chronic%20kidney%20disease%20from%20Asian%20Forum%20for%20Chronic%20Kidney%20Disease%20Initiatives%20(AFCKDI)&rft.jtitle=Nephrology%20(Carlton,%20Vic.)&rft.au=LI,%20PHILIP%20KAM-TAO&rft.aucorp=Asian%20Forum%20for%20Chronic%20Kidney%20Disease%20Initiatives&rft.date=2011-09&rft.volume=16&rft.issue=7&rft.spage=633&rft.epage=641&rft.pages=633-641&rft.issn=1320-5358&rft.eissn=1440-1797&rft_id=info:doi/10.1111/j.1440-1797.2011.01503.x&rft_dat=%3Cwiley_pubme%3ENEP1503%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21771177&rfr_iscdi=true |